ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
15 announcements with these filters
Abbott India Ltd reported revenue from operations of ₹1,951 Cr (+11.0% YoY) and net profit of ₹453.4 Cr (+9.2% YoY) for Q2 FY27.
Abbott India intimated BSE that its Board will meet on 5 Nov 2026 to approve Q2/H1 FY27 unaudited results. No financial figures are disclosed in this advance notice.
Abbott India Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b) of the SEBI LODR Regulations. The report details the equity distribution among various shareholder categories.
Abbott India submitted the quarterly certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, regarding dematerialization of securities.
Ms. Sangeeta Shetty has resigned as Company Secretary and Compliance Officer of Abbott India Limited, effective October 28, 2026.
Abbott India Ltd held its 82nd Annual General Meeting on August 13, 2026. Key business items, including dividend declaration and appointments, were discussed.
Abbott India Ltd reported revenue from operations of ₹1,814 Cr (+4.3% YoY) and net profit of ₹428.5 Cr (+17.1% YoY) for Q1 FY27.
Abbott India will hold a board meeting on August 12, 2026, to consider and approve its unaudited financial results for the quarter ended June 30, 2026.
Abbott India Ltd has provided the web-link to access its Annual Report for the financial year 2025-26 to its shareholders.
Abbott India Limited has submitted its Business Responsibility and Sustainability Report for the financial year 2025-26, as required by SEBI Listing Regulations.
Abbott India Limited has issued the notice for its 82nd Annual General Meeting, scheduled to be held on August 13, 2026.
Abbott India Ltd submitted its Annual Report for FY 2025-26. The company also notified the 82nd AGM scheduled for August 13, 2026.
Abbott India appointed Ms. Swati Pathak as Associate Director - Operations effective June 1, 2026. She brings 22 years of pharmaceutical experience to the senior management team.
Abbott India Limited submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report confirms overall adherence to statutory provisions.
Abbott India Limited issued a postal ballot notice to appoint Mr. James Wenner and Mr. Neeraj Jain. Shareholders will vote electronically between May 18 and June 16.